[go: up one dir, main page]

AU3924193A - Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid - Google Patents

Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid

Info

Publication number
AU3924193A
AU3924193A AU39241/93A AU3924193A AU3924193A AU 3924193 A AU3924193 A AU 3924193A AU 39241/93 A AU39241/93 A AU 39241/93A AU 3924193 A AU3924193 A AU 3924193A AU 3924193 A AU3924193 A AU 3924193A
Authority
AU
Australia
Prior art keywords
nonaqueous
compositions
drug delivery
delivery vehicle
fluorinated liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39241/93A
Other languages
English (en)
Inventor
David Louis Meadows
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of AU3924193A publication Critical patent/AU3924193A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU39241/93A 1992-03-19 1993-03-16 Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid Abandoned AU3924193A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85382792A 1992-03-19 1992-03-19
US853827 1992-03-19

Publications (1)

Publication Number Publication Date
AU3924193A true AU3924193A (en) 1993-10-21

Family

ID=25317012

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39241/93A Abandoned AU3924193A (en) 1992-03-19 1993-03-16 Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid

Country Status (2)

Country Link
AU (1) AU3924193A (fr)
WO (1) WO1993018748A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874469A (en) * 1996-01-05 1999-02-23 Alcon Laboratories, Inc. Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6291425B1 (en) 1999-09-01 2001-09-18 Guilford Pharmaceuticals Inc. Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage
RU2259817C2 (ru) * 2000-10-13 2005-09-10 Кембридж Байостэбилити Лтд. Композиция для доставки стабильных инъецируемых жидкостей и способ доставки
MXPA03003236A (es) * 2000-10-13 2004-12-03 Cambridge Biostability Ltd Composicion y metodo para liquidos inyectables estables.
DE60043459D1 (de) * 2000-10-13 2010-01-14 Cambridge Biostability Ltd Pharmazeutische flüssige Suspensionen
KR20030079990A (ko) * 2001-02-15 2003-10-10 가부시키가이샤산와카가쿠켄큐쇼 신규 안과용 조성물
US20070219127A1 (en) * 2006-03-20 2007-09-20 Walt John G Cyclosporin a compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI841513L (fi) * 1982-08-17 1984-04-16 Sun Tech Inc Perfluorcarbonemulsioner och deras framstaellning och anvaendning vid terapi.
IL84911A (en) * 1987-12-22 1993-04-04 Yissum Res Dev Co Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
WO1991018613A1 (fr) * 1990-06-01 1991-12-12 Research Corporation Technologies, Inc. Verres autoemulsifiants
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions

Also Published As

Publication number Publication date
WO1993018748A1 (fr) 1993-09-30

Similar Documents

Publication Publication Date Title
AU4534593A (en) Compositions and methods for enhanced drug delivery
AU664807B2 (en) Drug delivery system
AU4989993A (en) Drug delivery system
AU3050892A (en) Delivery system
AU7676894A (en) Convection-enhanced drug delivery
AU1689295A (en) Medication administration system with medication dispensing and storing modules
HK1007112B (en) Intravenous delivery system
AU4976293A (en) Medicament dispensing device
EP0704661A3 (fr) Système de distribution de cryogène liquide
AU7840994A (en) Active substance delivery system
AU7247894A (en) Liquid delivery apparatus
AU2979692A (en) Liquid pump dispenser
AU3154895A (en) Tastemasked liquid pharmaceutical delivery system
AU4649493A (en) Improved bubble gum formulation
AU3924193A (en) Compositions comprising a drug delivery vehicle suspended in a nonaqueous fluorinated liquid
AU4266293A (en) Delivery vehicle handling system
AU6708994A (en) Foam cell drug delivery
AU4576693A (en) Animated display
AU4976393A (en) Medicament dispensing device
AU6428994A (en) Formulation for nasal insulin delivery
GB2299282B (en) Liquid delivery nozzle
AU3613093A (en) Fold-up display container
AU5285993A (en) N-t-butylaniline analog and lipid level depressant containing the same
AU4957093A (en) Liquid dispenser
GB2279553A8 (en) Liquid delivery device